| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
19,660,000 |
| Market
Cap: |
374.72(M) |
| Last
Volume: |
40,587 |
Avg
Vol: |
53,266 |
| 52
Week Range: |
$10.34 - $20.87 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nature's Sunshine Products is a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. Co. has four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature's Sunshine Products and Synergy® WorldWide brands. The Latin America and Other segment includes Co.'s wholesale business. Co.'s line of products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
74,343 |
| Total Buy Value |
$0 |
$0 |
$0 |
$715,567 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
21 |
| Total Shares Sold |
0 |
18,999 |
82,569 |
87,541 |
| Total Sell Value |
$0 |
$326,183 |
$1,186,390 |
$1,227,061 |
| Total People Sold |
0 |
2 |
3 |
3 |
| Total Sell Transactions |
0 |
3 |
20 |
21 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Silcock Edward |
EVP & President, North America |
• – – |
2022-03-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(829) |
34,378 |
|
- |
|
| Baty Joseph W |
EVP & Chief Financial Officer |
• – – |
2022-03-30 |
4 |
D |
$16.79 |
$47,197 |
D/D |
(2,811) |
147,264 |
|
- |
|
| Yates Bryant J |
EVP & President, Europe |
• – – |
2022-03-30 |
4 |
D |
$16.79 |
$14,171 |
D/D |
(844) |
73,538 |
|
- |
|
| Brower Nathan G |
EVP, General Counsel |
• – – |
2022-03-30 |
4 |
D |
$16.79 |
$9,621 |
D/D |
(573) |
39,419 |
|
- |
|
| Norman Daniel C |
EVP & President, Asia |
• – – |
2022-03-30 |
4 |
D |
$16.79 |
$14,171 |
D/D |
(844) |
60,306 |
|
- |
|
| Moorehead Terrence |
Chief Executive Officer |
• • – |
2022-03-29 |
4 |
D |
$17.15 |
$193,229 |
D/D |
(11,267) |
373,434 |
|
- |
|
| Silcock Edward |
EVP & President, North America |
• – – |
2022-03-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,983 |
|
-36% |
|
| Baty Joseph W |
EVP & Chief Financial Officer |
• – – |
2022-03-26 |
4 |
D |
$17.23 |
$20,349 |
D/D |
(1,181) |
150,075 |
|
- |
|
| Brower Nathan G |
EVP, General Counsel |
• – – |
2022-03-26 |
4 |
D |
$17.23 |
$10,976 |
D/D |
(637) |
39,992 |
|
- |
|
| Silcock Edward |
EVP & President, North America |
• – – |
2022-03-26 |
4 |
D |
$17.23 |
$13,370 |
D/D |
(776) |
35,207 |
|
- |
|
| Yates Bryant J |
EVP & President, Europe |
• – – |
2022-03-26 |
4 |
D |
$17.23 |
$10,579 |
D/D |
(614) |
74,382 |
|
- |
|
| Norman Daniel C |
EVP & President, Asia |
• – – |
2022-03-26 |
4 |
D |
$17.23 |
$10,579 |
D/D |
(614) |
61,150 |
|
- |
|
| Norman Daniel C |
EVP & President, AsiaOfficer |
• – – |
2022-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,764 |
|
-39% |
|
| Yates Bryant J |
EVP & President, EuropeOfficer |
• – – |
2022-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
74,996 |
|
-39% |
|
| Brower Nathan G |
EVP, General CounselOfficer |
• – – |
2022-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,629 |
|
-39% |
|
| Moorehead Terrence |
Chief Executive Officer |
• • – |
2022-03-18 |
4 |
D |
$17.03 |
$87,653 |
D/D |
(5,147) |
384,701 |
|
- |
|
| Moorehead Terrence |
Chief Executive Officer |
• • – |
2022-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,077 |
389,848 |
|
- |
|
| Baty Joseph W |
EVP & Chief Financial Officer |
• – – |
2022-03-02 |
4 |
D |
$17.42 |
$21,357 |
D/D |
(1,226) |
151,256 |
|
- |
|
| Baty Joseph W |
EVP & Chief Financial Officer |
• – – |
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,482 |
152,482 |
|
- |
|
| Moorehead Terrence |
Chief Executive Officer |
• • – |
2022-03-02 |
4 |
D |
$17.42 |
$41,616 |
D/D |
(2,389) |
376,771 |
|
- |
|
| Moorehead Terrence |
Chief Executive Officer |
• • – |
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,804 |
379,160 |
|
- |
|
| Moorehead Terrence |
CEO |
• • – |
2022-01-25 |
4 |
D |
$17.86 |
$56,741 |
D/D |
(3,177) |
369,356 |
|
- |
|
| Moorehead Terrence |
CEO |
• • – |
2022-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,077 |
372,533 |
|
- |
|
| Shanghai Fosun Pharmaceutical (group) Co., Ltd. |
10% Owner |
– – • |
2022-01-21 |
4 |
A |
$8.72 |
$218,000 |
I/I |
25,000 |
74,394 |
|
- |
|
| Moorehead Terrence |
CEO |
• • – |
2022-01-14 |
4 |
D |
$18.61 |
$51,922 |
D/D |
(2,790) |
359,456 |
|
- |
|
640 Records found
|
|
Page 6 of 26 |
|
|
0.32 (1.65%) 
